The World Congress on NeuroTherapeutics: Dilemmas, Debates & Discussions (DDDN) 2014

  • Conference Call
  • The World Con­gress on Neu­roTher­a­peu­tics: Dilem­mas, Debates & Dis­cus­sions (DDDN) is a com­pre­hen­sive Con­gress fully devoted to neu­rother­a­peu­tic top­ics, which will be held in Basel, Switzer­land, Sep­tem­ber 4 – 7, 2014. The con­gress is aimed at inter­ac­tion between med­ical spe­cial­ists, neu­ro­sci­en­tists and the indus­try. The speak­ers will present an overview of the fields such as Stroke, Alzheimer’s Dis­ease, MS, etc.)

    Con­fer­ence Topics

    Gen­eral Sessions

    Stem Cell Ther­apy in Neurology

    This ses­sion will deal with the hottest neu­rother­a­peu­tic topic in the media. The focus will be on both neu­rode­gen­er­a­tion and inflam­ma­tory CNS diseases.

    Prac­ti­cal Abstract Ses­sion — Ther­a­peu­tic Dilemmas

    Selected com­pli­cated cases, sub­mit­ted by the par­tic­i­pants in advance, to be dis­cussed by a panel of experts

    The Future of Neurotherapeutics

    This ses­sion is aimed at inter­ac­tion between med­ical spe­cial­ists, neu­ro­sci­en­tists and the indus­try. The speak­ers (experts or field inves­ti­ga­tors) will present an overview of the future in their fields (stroke, Alzheimer, ALS, MS) and will allow com­ments from the audience.

    Par­al­lel Symposia

    Dis­ease Mod­i­fy­ing Drugs for Mul­ti­ple Scle­ro­sis: What should be the End­points in Clin­i­cal Trials?

    This ses­sion is aimed at neu­rol­o­gists (clin­i­cians and aca­d­e­mi­cians) car­ing for MS patients or involved in ther­a­peu­tic tri­als. It will present the topic in a debate format.

    Acute Ther­apy for Stroke

    This ses­sion is for a mixed crowd of in hos­pi­tal and out­pa­tient neu­rol­o­gists. It deals with the most preva­lent dis­abling neu­ro­log­i­cal con­di­tions at a time of fast devel­op­ment in this field.

    Dilem­mas of Neu­ro­log­i­cal Ther­apy Prac­tice dur­ing Pregnancy

    This ses­sion is aimed at the prac­tic­ing neu­rol­o­gist (in hos­pi­tal or out­pa­tient clinic). It deals with com­mon neu­ro­log­i­cal dis­or­ders in preg­nant women. Spe­cial time will be avail­able for the audi­ence to raise issues related to neu­ro­log­i­cal ther­apy dur­ing preg­nancy in a Q & A format.

    Ther­a­peu­tic Brain Stim­u­la­tion (Elec­tric and Magnetic)

    This ses­sion is devoted to func­tional neu­rother­a­peu­tics in com­mon neu­ro­log­i­cal dis­eases. It is aimed at neu­ro­sci­en­tists and neu­ro­sur­geons in addi­tion to neurologists.

    Ther­a­peu­tic Dilem­mas in Mul­ti­ple Sclerosis

    This ses­sion is for a mixed crowd of neu­roim­muno­log­i­cal spe­cial­ists and prac­tic­ing neu­rol­o­gists. It deals with prac­ti­cal issues in the advanced MS patient.

    The Ethics of Human Ther­apy Trials

    IRBs have become an essen­tial ele­ment of clin­i­cal trial. Have they become a hur­dle? The ses­sion will focus on the var­i­ous admin­is­tra­tive and legal aspects of the sys­tem and will con­clude with a debate.

    Neu­ro­log­i­cal (Cog­ni­tive) Enhancement

    This ses­sion touches upon an emerg­ing con­tro­ver­sial topic in neu­rother­apy: should we med­icate or oth­er­wise treat the ‘nor­mal’ sub­ject? Prac­ti­cal and eth­i­cal issues will be raised.

    Epilepsy Therapy

    This ses­sion is aimed at the prac­tic­ing and aca­d­e­mic neu­rol­o­gist. It will present new approaches as well as com­mon prac­ti­cal dilem­mas with ample time for expert opin­ion and audi­ence input.

    Steroids in Neu­ro­log­i­cal Diseases

    A prac­ti­cal ses­sion deal­ing with con­tro­ver­sial top­ics when pre­scrib­ing steroids in neu­ro­log­i­cal dis­eases: Should they be used and how? Time will be allowed for the audi­ence to raise ques­tions and meet the experts.

    CME Accreditation

    Accreditation

    Serono Sym­posia Inter­na­tional Foun­da­tion will sub­mit the main con­gress pro­gram of the World Con­gress on Con­tro­ver­sies in Neu­rol­ogy (DDDN), Basel, Switzer­land, Sep­tem­ber 4 – 7, 2014, for accred­i­ta­tion by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EACCME).

    For the Ital­ian participants

    The World Con­gress on Con­tro­ver­sies in Neu­rol­ogy (DDDN), Basel, Switzer­land, Sep­tem­ber 4 – 7, 2014 pro­gram will be sub­mit­ted for CME accred­i­ta­tion from the Ital­ian Min­istry of Health.

    The CME accred­i­ta­tion is valid for the main con­gress pro­gram only and does not cover the company-​sponsored symposia.

    ISO 9001 Certification

    Serono Sym­posia Inter­na­tional Foun­da­tion has received the ISO 9001 Cer­ti­fi­ca­tion of Qual­ity Man­age­ment Sys­tems. This Qual­ity cer­ti­fi­ca­tion requires all par­tic­i­pants to fill in a sci­en­tific ques­tion­naire and to eval­u­ate the over­all qual­ity of the event. Ques­tion­naires will be dis­trib­uted onsite dur­ing the congress.

    CME for USA participants

    UEMS/​EACCME CME credit recognition

    The Amer­i­can Med­ical Asso­ci­a­tion (AMA) has an agree­ment of mutual recog­ni­tion of con­tin­u­ing med­ical edu­ca­tion (CME) credit with the Euro­pean Union of Med­ical Spe­cial­ties (UEMS). Under the terms of this agree­ment, the AMA will con­vert CME credit cer­ti­fied by the Euro­pean Accred­i­ta­tion Coun­cil for Con­tin­u­ing Med­ical Edu­ca­tion (EAC­CME), the accred­it­ing arm of the UEMS, to AMA PRA Cat­e­gory 1 Credit™. Physi­cians (MDs, DOs or equiv­a­lent inter­na­tional degree) may have their EAC­CME credit con­verted to AMA PRA Cat­e­gory 1 Credit™ by apply­ing to the AMA.

    starting: ending: 07.09.2014 Location: , Category:

    Timeline

    Conference START 07.09.2014 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Stadt-Casino Basel, Steinenberg 14 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.